181 related articles for article (PubMed ID: 25161312)
1. Sex-dependent differential activation of NLRP3 and AIM2 inflammasomes in SLE macrophages.
Yang CA; Huang ST; Chiang BL
Rheumatology (Oxford); 2015 Feb; 54(2):324-31. PubMed ID: 25161312
[TBL] [Abstract][Full Text] [Related]
2. Macrophage IL-1β contributes to tumorigenesis through paracrine AIM2 inflammasome activation in the tumor microenvironment.
Chew ZH; Cui J; Sachaphibulkij K; Tan I; Kar S; Koh KK; Singh K; Lim HM; Lee SC; Kumar AP; Gasser S; Lim LHK
Front Immunol; 2023; 14():1211730. PubMed ID: 37449203
[TBL] [Abstract][Full Text] [Related]
3. Clustering human dental pulp fibroblasts spontaneously activate NLRP3 and AIM2 inflammasomes and induce IL-1β secretion.
Zhai S; Zhang L; Li X; Yu Q; Liu C
Regen Ther; 2024 Dec; 27():12-20. PubMed ID: 38487102
[TBL] [Abstract][Full Text] [Related]
4. Identification of potential biomarkers for SLE through mRNA expression profiling.
Rizk SK; Alhosary A; Zahran ES; Awad S; Khalil M
J Immunoassay Immunochem; 2024 Jan; 45(1):20-37. PubMed ID: 37807897
[TBL] [Abstract][Full Text] [Related]
5.
Singh MK; Rallabandi HR; Zhou XJ; Qi YY; Zhao ZZ; Gan T; Zhang H; Looger LL; Nath SK
Ann Rheum Dis; 2024 Jun; 83(7):879-888. PubMed ID: 38373841
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy activates inflammasomes to cause inflammation-associated bone loss.
Wang C; Kaur K; Xu C; Abu-Amer Y; Mbalaviele G
Elife; 2024 Apr; 13():. PubMed ID: 38602733
[TBL] [Abstract][Full Text] [Related]
7. Aberrant inflammasome activation as a driving force of human autoimmune skin disease.
Fetter T; de Graaf DM; Claus I; Wenzel J
Front Immunol; 2023; 14():1190388. PubMed ID: 37325658
[TBL] [Abstract][Full Text] [Related]
8. Cutting Edge: Cytosolic Receptor AIM2 Is Induced by Peroxisome Proliferator-activated Receptor γ following Mycobacterium tuberculosis Infection of Human Macrophages but Does Not Contribute to IL-1β Release.
Arnett E; Wolff J; Leopold Wager CM; Simper J; Badrak JL; Ontiveros CO; Ni B; Schlesinger LS
J Immunol; 2024 Mar; 212(5):765-770. PubMed ID: 38251918
[TBL] [Abstract][Full Text] [Related]
9. Cell swelling and the NLRP3 inflammasome.
Boyle JP; Bryant CE; Monie TP
Immunity; 2013 Mar; 38(3):399. PubMed ID: 23521876
[No Abstract] [Full Text] [Related]
10. Correction to: Erythropoietin Abrogates Post-Ischemic Activation of the NLRP3, NLRC4, and AIM2 Inflammasomes in Microglia/Macrophages in a TAK1-Dependent Manner.
Heinisch O; Zeyen T; Goldmann T; Prinz M; Huber M; Jung J; Arik E; Habib S; Slowik A; Reich A; Schulz JB; Habib P
Transl Stroke Res; 2024 Jun; 15(3):689-690. PubMed ID: 37344721
[No Abstract] [Full Text] [Related]
11. Structural mechanisms in NLR inflammasome signaling.
Lechtenberg BC; Mace PD; Riedl SJ
Curr Opin Struct Biol; 2014 Dec; 29():17-25. PubMed ID: 25201319
[TBL] [Abstract][Full Text] [Related]
12. CD39 is a negative regulator of P2X7-mediated inflammatory cell death in mast cells.
Kuhny M; Hochdörfer T; Ayata CK; Idzko M; Huber M
Cell Commun Signal; 2014 Jul; 12():40. PubMed ID: 25184735
[TBL] [Abstract][Full Text] [Related]
13. An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome.
Canna SW; de Jesus AA; Gouni S; Brooks SR; Marrero B; Liu Y; DiMattia MA; Zaal KJ; Sanchez GA; Kim H; Chapelle D; Plass N; Huang Y; Villarino AV; Biancotto A; Fleisher TA; Duncan JA; O'Shea JJ; Benseler S; Grom A; Deng Z; Laxer RM; Goldbach-Mansky R
Nat Genet; 2014 Oct; 46(10):1140-6. PubMed ID: 25217959
[TBL] [Abstract][Full Text] [Related]
14. The E3 ubiquitin ligase tripartite motif 33 is essential for cytosolic RNA-induced NLRP3 inflammasome activation.
Weng L; Mitoma H; Trichot C; Bao M; Liu Y; Zhang Z; Liu YJ
J Immunol; 2014 Oct; 193(7):3676-82. PubMed ID: 25172487
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial ROS potentiates indirect activation of the AIM2 inflammasome.
Crane DD; Bauler TJ; Wehrly TD; Bosio CM
Front Microbiol; 2014; 5():438. PubMed ID: 25191316
[TBL] [Abstract][Full Text] [Related]
16. Free fatty acids as modulators of the NLRP3 inflammasome in obesity/type 2 diabetes.
Legrand-Poels S; Esser N; L'homme L; Scheen A; Paquot N; Piette J
Biochem Pharmacol; 2014 Nov; 92(1):131-41. PubMed ID: 25175736
[TBL] [Abstract][Full Text] [Related]
17. Xenobiotic pregnane X receptor (PXR) regulates innate immunity via activation of NLRP3 inflammasome in vascular endothelial cells.
Wang S; Lei T; Zhang K; Zhao W; Fang L; Lai B; Han J; Xiao L; Wang N
J Biol Chem; 2014 Oct; 289(43):30075-81. PubMed ID: 25202020
[TBL] [Abstract][Full Text] [Related]
18. IKKα negatively regulates ASC-dependent inflammasome activation.
Martin BN; Wang C; Willette-Brown J; Herjan T; Gulen MF; Zhou H; Bulek K; Franchi L; Sato T; Alnemri ES; Narla G; Zhong XP; Thomas J; Klinman D; Fitzgerald KA; Karin M; Nuñez G; Dubyak G; Hu Y; Li X
Nat Commun; 2014 Sep; 5():4977. PubMed ID: 25266676
[TBL] [Abstract][Full Text] [Related]
19. The emerging role of human PYHIN proteins in innate immunity: implications for health and disease.
Connolly DJ; Bowie AG
Biochem Pharmacol; 2014 Dec; 92(3):405-14. PubMed ID: 25199457
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-10 regulates the inflammasome-driven augmentation of inflammatory arthritis and joint destruction.
Greenhill CJ; Jones GW; Nowell MA; Newton Z; Harvey AK; Moideen AN; Collins FL; Bloom AC; Coll RC; Robertson AA; Cooper MA; Rosas M; Taylor PR; O'Neill LA; Humphreys IR; Williams AS; Jones SA
Arthritis Res Ther; 2014 Aug; 16(4):419. PubMed ID: 25175678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
